LC-MS

  • Preventing The Next Pandemic: Leveraging the Andrew+ Pipetting Robot and Extraction+ Connected Device to Monitor Antimicrobials in Hospital Wastewater

    Dr. Takashi Azuma’s research on hospital wastewater monitoring at Osaka Medical and Pharmaceutical University may prevent the next global pandemic. Five years later, it is difficult to forget the horror of the Covid-19 pandemic. Leaving behind a death toll estimated at between 18.2 million to 33.5 million, the greatest recession since the Great Depression, and…

  • Biophysical Characterization Methodologies

    Biophysical characterization of proteins is a necessary step in the production and development of protein therapeutics, as it allows for a comprehensive understanding of a protein’s function and structure. By analyzing and defining the higher-order structure of potential drug targets, this process serves to identify and mitigate issues that could significantly impact the efficacy and safety of a product, such as…

  • The IVDR Cake. We’ve got a slice!

    Healthcare Providers and medical device manufacturers alike are working diligently to ensure that their services and products are compliant with these new regulations in the medical device industry in the European Union (EU).

  • Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM

    The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification variants (attributes) creates an interesting analytical challenge for scientists tasked with their characterization and then with monitoring those attributes important…

  • Embracing Analytical Techniques Into Regulated Laboratories

    To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.

  • Comprehending COVID-19: How Consumables Can Increase LC-MS/MS Sensitivity

    During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological specimen, the sample collection medium, the viral load threshold, and the need for a high throughput method gave rise to…